31 July, 2010
Avandia increases the risk of fractures in women over 50 and in men who also take loop diuretics, according a new study published in the Journal of Clinical Endocrinology & Metabolism.
The new study examined diabetes treatments and fractures using data from the TRIAD study of diabetic patients in managed care settings. Continue reading New study links TZDs Actos and Avandia to fracture risk
Category: Avandia News | Avandia Safety | Avandia Side Effects27 July, 2010
FDA puts Avandia drug safety TIDE trial on clinical hold pending Avandia side effects risks review.
The FDA has given notice to Avandia drug manufacturer GlaxoSmithKline that the TIDE trial has been put on clinical hold pending review of Avandia safety information presented at the FDA Advisory Committee meeting on Avandia drug safety held July 13 and 14, 2010. The complete FDA statement is set out in full. Continue reading FDA Statement on Avandia TIDE Trial
Category: Avandia FDA | Avandia News27 July, 2010
A heart attack is the sudden death heart cells due to inadequate blood flow to part of the heart.
A heart attack occurs when blood supply to an area of the heart is cut off by a clot blocking coronary artery blood flow to the heart. Heart damages caused by heart attack oxygen deprivation can rapidly lead to permanent disability and death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of heart attack. Continue reading Avandia Heart Attack Lawsuit
Category: Avandia Cardiovascular Risk | Avandia Side Effects25 July, 2010
A stroke is the sudden death of brain cells due to inadequate blood flow to part of the brain.
A stroke occurs when blood flow to an area of the brain is cut off by a blockage or rupture of a blood vessel to or within the brain. Damage to brain cells caused by stroke-related oxygen deprivation can rapidly lead to permanent disability and death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of stroke. Continue reading Avandia Stroke Lawsuit
Category: Avandia Cardiovascular Risk | Avandia Side Effects22 July, 2010
While Avandia side effects data are being reviewed by the FDA, Avandia lawsuit settlements are being reached, and an Avandia recall still is being considered, the FDA has barred new diabetes patients from participating in the TIDE trial. Continue reading FDA Avandia news on TIDE: New patients barred
Category: Avandia FDA | Avandia News | Avandia Recall | Avandia Safety | Avandia Side Effects21 July, 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
GlaxosmithKline’s press release in response to FDA Avandia news that a “partial clinical hold” barring new diabetes patients from enrolling in the TIDE trial had been issued while Avandia side effects data are reviewed. Continue reading FDA Avandia news on TIDE trial: GSK's press release response
Category: Avandia FDA | Avandia News18 July, 2010
GlaxoSmithKline has agreed to Avandia lawsuit settlements totaling about $460 million
Our experienced Avandia lawsuit attorneys are accepting cases in all 50 states. If you or a loved has suffered an Avandia heart attack, stroke, heart failure or Avandia heart-related death, call us toll free at 800-845-6913 or fill out our short online contact form and an Avandia lawsuit attorney will contact you for a free no-obligation consultation. Let us answer all of your questions and help you recover the compensation you deserve. Continue reading Avandia Lawsuit Settlements
Category: Avandia Lawsuit | Avandia Settlements | Avandia Side Effects16 July, 2010
Avandia lawsuits have been filed by diabetics and their families against drug manufacturer GlaxoSmithKline to collect financial compensation for personal injury and wrongful death damages.
Avandia lawsuit attorneys claim GSK intentionally misled doctors and the public about the drug’s safety and efficacy. Lawyers also claim Glaxo was negligent. Please contact us for the latest Avandia lawsuit 2010 news. Continue reading Avandia Lawsuit 2010 Information
Category: Avandia Lawsuit | Avandia News14 July, 2010
On July 14, 2010, the joint FDA drug advisory panel on Avandia safety voted NOT to recall Avandia, GlaxoSmithKline’s controversial Type 2 Diabetes medicine.
How did the 33 members of the FDA advisory committee vote when asked what regulatory action should be taken on Avandia by the U.S. Food and Drug Administration? Here are the number of votes received for each of the options: Continue reading FDA Panel Vote NO AVANDIA RECALL, Revise Warning, Restrict Use
Category: Avandia FDA | Avandia News | Avandia Recall13 July, 2010
Joint Meeting
Endocrinologic and Metabolic Drugs Advisory Committee
and
Drug Safety and Risk Management Advisory Committee
Hilton Washington DC North/Gaithersburg
July 13 – 14, 2010
Meeting Roster
A list of 47 experts at the joint FDA drug advisory committee meeting to evaluate Avandia safety data, cardiovascular/heart risk, side effects and an Avandia recall. Continue reading FDA Avandia Safety Joint Advisory Committee Meeting Roster - Experts
Category: Avandia FDA | Avandia Recall | Avandia Safety | Avandia Side Effects | Avandia Warning